nodes	percent_of_prediction	percent_of_DWPC	metapath
Bethanidine—SLC6A2—locus ceruleus—Parkinson's disease	0.124	0.231	CbGeAlD
Bethanidine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.0978	0.183	CbGeAlD
Bethanidine—KCNJ1—Inwardly rectifying K+ channels—KCNJ4—Parkinson's disease	0.0669	0.18	CbGpPWpGaD
Bethanidine—SLC6A2—autonomic nervous system—Parkinson's disease	0.0657	0.123	CbGeAlD
Bethanidine—KCNJ1—forebrain—Parkinson's disease	0.0448	0.0837	CbGeAlD
Bethanidine—KCNJ1—Potassium Channels—HCN3—Parkinson's disease	0.041	0.11	CbGpPWpGaD
Bethanidine—SLC6A2—nerve—Parkinson's disease	0.037	0.0692	CbGeAlD
Bethanidine—KCNJ1—Potassium Channels—KCNJ4—Parkinson's disease	0.0264	0.0712	CbGpPWpGaD
Bethanidine—KCNJ1—head—Parkinson's disease	0.0256	0.0479	CbGeAlD
Bethanidine—KCNJ1—nervous system—Parkinson's disease	0.0243	0.0454	CbGeAlD
Bethanidine—KCNJ1—central nervous system—Parkinson's disease	0.0234	0.0438	CbGeAlD
Bethanidine—SLC6A2—Monoamine Transport—DBH—Parkinson's disease	0.0191	0.0513	CbGpPWpGaD
Bethanidine—KCNJ1—brain—Parkinson's disease	0.0186	0.0347	CbGeAlD
Bethanidine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—Parkinson's disease	0.0181	0.0486	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—HCN3—Parkinson's disease	0.0179	0.0482	CbGpPWpGaD
Bethanidine—SLC6A2—brainstem—Parkinson's disease	0.0159	0.0297	CbGeAlD
Bethanidine—SLC6A2—forebrain—Parkinson's disease	0.0153	0.0287	CbGeAlD
Bethanidine—SLC6A2—Amine compound SLC transporters—SLC18A2—Parkinson's disease	0.0125	0.0337	CbGpPWpGaD
Bethanidine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Parkinson's disease	0.0118	0.0319	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—KCNJ4—Parkinson's disease	0.0115	0.0311	CbGpPWpGaD
Bethanidine—SLC6A2—medulla oblongata—Parkinson's disease	0.0111	0.0207	CbGeAlD
Bethanidine—SLC6A2—Monoamine Transport—ADORA2A—Parkinson's disease	0.0104	0.0281	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—DLG1—Parkinson's disease	0.00996	0.0268	CbGpPWpGaD
Bethanidine—Isocarboxazid—MAOB—Parkinson's disease	0.00918	0.0977	CrCbGaD
Bethanidine—SLC6A2—head—Parkinson's disease	0.00877	0.0164	CbGeAlD
Bethanidine—SLC6A2—nervous system—Parkinson's disease	0.00832	0.0156	CbGeAlD
Bethanidine—SLC6A2—Amine compound SLC transporters—SLC6A3—Parkinson's disease	0.00822	0.0221	CbGpPWpGaD
Bethanidine—SLC6A2—central nervous system—Parkinson's disease	0.00801	0.015	CbGeAlD
Bethanidine—SLC6A2—Monoamine Transport—TH—Parkinson's disease	0.0078	0.021	CbGpPWpGaD
Bethanidine—SLC6A2—Monoamine Transport—SLC6A3—Parkinson's disease	0.0078	0.021	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—GRIK1—Parkinson's disease	0.00779	0.021	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—GRIK2—Parkinson's disease	0.00663	0.0178	CbGpPWpGaD
Bethanidine—Isocarboxazid—MAOA—Parkinson's disease	0.00643	0.0685	CrCbGaD
Bethanidine—KCNJ1—Neuronal System—SLC18A2—Parkinson's disease	0.00642	0.0173	CbGpPWpGaD
Bethanidine—SLC6A2—brain—Parkinson's disease	0.00636	0.0119	CbGeAlD
Bethanidine—Pargyline—MAOB—Parkinson's disease	0.00591	0.063	CrCbGaD
Bethanidine—Ephedrine—SLC18A2—Parkinson's disease	0.00582	0.062	CrCbGaD
Bethanidine—KCNJ1—Neuronal System—CHRNA4—Parkinson's disease	0.00508	0.0137	CbGpPWpGaD
Bethanidine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.0049	0.0132	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—HSPA8—Parkinson's disease	0.00466	0.0125	CbGpPWpGaD
Bethanidine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00451	0.0121	CbGpPWpGaD
Bethanidine—Dextroamphetamine—SLC18A2—Parkinson's disease	0.00444	0.0473	CrCbGaD
Bethanidine—KCNJ1—Neuronal System—DLG4—Parkinson's disease	0.00437	0.0118	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—GRIN2B—Parkinson's disease	0.00427	0.0115	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—SLC6A3—Parkinson's disease	0.00421	0.0113	CbGpPWpGaD
Bethanidine—L-Phenylalanine—TH—Parkinson's disease	0.00419	0.0446	CrCbGaD
Bethanidine—Pargyline—MAOA—Parkinson's disease	0.00415	0.0442	CrCbGaD
Bethanidine—SLC6A2—NRF2 pathway—GSTA4—Parkinson's disease	0.00392	0.0106	CbGpPWpGaD
Bethanidine—Amphetamine—SLC18A2—Parkinson's disease	0.00358	0.0381	CrCbGaD
Bethanidine—KCNJ1—Neuronal System—COMT—Parkinson's disease	0.00358	0.00963	CbGpPWpGaD
Bethanidine—KCNJ1—Neuronal System—MAOA—Parkinson's disease	0.00355	0.00957	CbGpPWpGaD
Bethanidine—Methamphetamine—SLC18A2—Parkinson's disease	0.00332	0.0353	CrCbGaD
Bethanidine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00321	0.00865	CbGpPWpGaD
Bethanidine—Phentermine—MAOB—Parkinson's disease	0.00319	0.034	CrCbGaD
Bethanidine—SLC6A2—Monoamine Transport—IL1B—Parkinson's disease	0.00318	0.00857	CbGpPWpGaD
Bethanidine—Selegiline—MAOB—Parkinson's disease	0.00296	0.0315	CrCbGaD
Bethanidine—Phenelzine—MAOB—Parkinson's disease	0.0026	0.0277	CrCbGaD
Bethanidine—Amphetamine—MAOB—Parkinson's disease	0.00246	0.0262	CrCbGaD
Bethanidine—SLC6A2—NRF2 pathway—NQO1—Parkinson's disease	0.00235	0.00633	CbGpPWpGaD
Bethanidine—SLC6A2—NRF2 pathway—HSPA1A—Parkinson's disease	0.00233	0.00628	CbGpPWpGaD
Bethanidine—SLC6A2—NRF2 pathway—SLC6A3—Parkinson's disease	0.00232	0.00624	CbGpPWpGaD
Bethanidine—SLC6A2—Monoamine Transport—TNF—Parkinson's disease	0.00231	0.00622	CbGpPWpGaD
Bethanidine—Methamphetamine—MAOB—Parkinson's disease	0.00228	0.0242	CrCbGaD
Bethanidine—Phentermine—MAOA—Parkinson's disease	0.00224	0.0238	CrCbGaD
Bethanidine—SLC6A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00223	0.00599	CbGpPWpGaD
Bethanidine—SLC6A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00213	0.00574	CbGpPWpGaD
Bethanidine—SLC6A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00213	0.00574	CbGpPWpGaD
Bethanidine—Pseudoephedrine—MAOA—Parkinson's disease	0.00212	0.0226	CrCbGaD
Bethanidine—Selegiline—MAOA—Parkinson's disease	0.00207	0.0221	CrCbGaD
Bethanidine—SLC6A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00205	0.00552	CbGpPWpGaD
Bethanidine—SLC6A2—NRF2 pathway—GSTP1—Parkinson's disease	0.00196	0.00528	CbGpPWpGaD
Bethanidine—SLC6A2—NRF2 pathway—HMOX1—Parkinson's disease	0.00193	0.0052	CbGpPWpGaD
Bethanidine—Phentermine—SLC6A3—Parkinson's disease	0.00193	0.0206	CrCbGaD
Bethanidine—Dextroamphetamine—SLC6A3—Parkinson's disease	0.00184	0.0196	CrCbGaD
Bethanidine—Pseudoephedrine—SLC6A3—Parkinson's disease	0.00183	0.0195	CrCbGaD
Bethanidine—Phenelzine—MAOA—Parkinson's disease	0.00183	0.0194	CrCbGaD
Bethanidine—SLC6A2—NRF2 pathway—HGF—Parkinson's disease	0.0018	0.00485	CbGpPWpGaD
Bethanidine—SLC6A2—NRF2 pathway—GSTM1—Parkinson's disease	0.0018	0.00485	CbGpPWpGaD
Bethanidine—Pseudoephedrine—TNF—Parkinson's disease	0.0017	0.0181	CrCbGaD
Bethanidine—Methamphetamine—MAOA—Parkinson's disease	0.0016	0.017	CrCbGaD
Bethanidine—Amphetamine—SLC6A3—Parkinson's disease	0.00148	0.0158	CrCbGaD
Bethanidine—Phenformin—CYP2D6—Parkinson's disease	0.00148	0.0158	CrCbGaD
Bethanidine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00146	0.00393	CbGpPWpGaD
Bethanidine—Methamphetamine—SLC6A3—Parkinson's disease	0.00138	0.0147	CrCbGaD
Bethanidine—Benzyl alcohol—CYP2E1—Parkinson's disease	0.00133	0.0142	CrCbGaD
Bethanidine—Selegiline—CYP2E1—Parkinson's disease	0.00128	0.0136	CrCbGaD
Bethanidine—SLC6A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00113	0.00305	CbGpPWpGaD
Bethanidine—Phenelzine—CYP2E1—Parkinson's disease	0.00113	0.012	CrCbGaD
Bethanidine—Amphetamine—DRD2—Parkinson's disease	0.0011	0.0118	CrCbGaD
Bethanidine—SLC6A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00104	0.0028	CbGpPWpGaD
Bethanidine—Phentermine—CYP2D6—Parkinson's disease	0.00101	0.0108	CrCbGaD
Bethanidine—Benzyl alcohol—CYP2D6—Parkinson's disease	0.000978	0.0104	CrCbGaD
Bethanidine—Dextroamphetamine—CYP2D6—Parkinson's disease	0.000968	0.0103	CrCbGaD
Bethanidine—Pseudoephedrine—CYP2D6—Parkinson's disease	0.000962	0.0102	CrCbGaD
Bethanidine—Selegiline—CYP2D6—Parkinson's disease	0.000939	0.01	CrCbGaD
Bethanidine—Amphetamine—CYP2D6—Parkinson's disease	0.00078	0.00831	CrCbGaD
Bethanidine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000742	0.002	CbGpPWpGaD
Bethanidine—Methamphetamine—CYP2D6—Parkinson's disease	0.000723	0.0077	CrCbGaD
Bethanidine—SLC6A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000712	0.00192	CbGpPWpGaD
Bethanidine—Selegiline—ABCB1—Parkinson's disease	0.00067	0.00714	CrCbGaD
Bethanidine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000619	0.00167	CbGpPWpGaD
Bethanidine—SLC6A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000594	0.0016	CbGpPWpGaD
